4.7 Article

High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopenia

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Restoration of tolerance in lupus by targeted inhibitory receptor expression

TL McGaha et al.

SCIENCE (2005)

Article Immunology

FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis

MR Clatworthy et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Article Medicine, General & Internal

Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

YF Cheng et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Medicine, Research & Experimental

C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex-induced lung disease

N Shushakova et al.

JOURNAL OF CLINICAL INVESTIGATION (2002)

Article Biochemistry & Molecular Biology

Regulated expression and inhibitory function of FcγRIIb in human monocytic cells

S Tridandapani et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Biochemistry & Molecular Biology

The Molecular Biology Database Collection: 2002 update

AD Baxevanis

NUCLEIC ACIDS RESEARCH (2002)